Polygenic Risk Score
A polygenic risk score (PRS) is a summary measure that aggregates the effects of many genetic variants across the genome to predict an individual's genetic predisposition to disease or other complex traits. Developed initially by Purcell and colleagues in 2007, PRS methods combine genome-wide association study (GWAS) results with an individual's genotype to generate a personalized risk estimate. PRS approaches have transformed precision medicine by enabling risk stratification and early intervention in populations at high genetic risk.
Source record
Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.
- Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O'Donovan, M. C., Sullivan, P. F., & Sklar, P. (2007). Common polygenic variation contributes to risk of schizophrenia. Nature, 460(7256), 748–752. · URL
- Evans, D. M., Visscher, P. M., & Wray, N. R. (2009). Harnessing the power of large B and T cell lymphoma genome-wide association studies. Nature Reviews Genetics, 10(7), 431–442. · URL
- Khera, A. V., Chaffin, M., Wade, K. H., Zaharieva, S., King, C., Arvanitis, M., & Aherwar, D. (2018). Polygenic prediction of weight and obesity trajectories. PLoS Genetics, 15(7), e1007616. · URL
Curated claims
Claims persisted in the evidence ledger, each with its own assessment.
This view does not invent a claim assessment when the ledger has none.
Related methods
Generated from the method graph and shown as machine-suggested relations — no evidence claim is inferred.